George J. Walsh III
CIK: 0001207140
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHE
CHEMED CORP
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 29, 2026CHE
CHEMED CORP
Sale(S)Direct500 shares at avg. $437.83$219K - May 18, 2026CHE
CHEMED CORP
Award(A)Direct386 shares at avg. $440.77$170K - Aug 4, 2025CHE
CHEMED CORP
Purchase(P)Direct200 shares at avg. $417.10$83K - May 19, 2025CHE
CHEMED CORP
Award(A)Direct277 shares at avg. $579.04$160K - Sep 26, 2024CHE
CHEMED CORP
Sale(S)Direct400 shares at avg. $597.47$239K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | CHE CHEMED CORP | Sale(S) | 500 | $437.83 | $218,915 | Direct |
| May 18, 2026 | CHE CHEMED CORP | Award(A) | 386 | $440.77 | $170,137 | Direct |
| Aug 4, 2025 | CHE CHEMED CORP | Purchase(P) | 200 | $417.10 | $83,420 | Direct |
| May 19, 2025 | CHE CHEMED CORP | Award(A) | 277 | $579.04 | $160,394 | Direct |
| Sep 26, 2024 | CHE CHEMED CORP | Sale(S) | 400 | $597.47 | $238,988 | Direct |
1-5 of 5 transactions
About WALSH GEORGE J III
WALSH GEORGE J III (SEC CIK 0001207140) files insider reports with the SEC as Director of CHEMED CORP (CHE).
Signal8 holds 5 ownership filings by WALSH GEORGE J III, all Form 4s, filed between Sep 27, 2024 and May 29, 2026. Those filings report 5 transactions, from Sep 26, 2024 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WALSH GEORGE J III's filings is in CINCINNATI, OH.
Recent filings by WALSH GEORGE J III
- May 29, 2026: Open-market sale of CHE shares (Form 4, code S).
- May 18, 2026: Grant or award of CHE shares (Form 4, code A).
- Aug 4, 2025: Open-market purchase of CHE shares (Form 4, code P).
- May 19, 2025: Grant or award of CHE shares (Form 4, code A).
- Sep 26, 2024: Open-market sale of CHE shares (Form 4, code S).
Other insiders filing for CHEMED CORP (CHE)
- LEE SPENCER S, executive vice president
- Wherley Joel L, CEO - Vitas Healthcare
- Judkins Brian C, VP and Chief Legal Officer
- HUTTON THOMAS C, vice president
- Witzeman Michael D, VP & Chief Financial Officer
- MCNAMARA KEVIN J, president and CEO